adenosine monophosphate has been researched along with Complication, Postoperative in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Alberio, L; Iafrate, M; Kirsch, M; Marcucci, C; Pantet, O; Pitta-Gros, B; Scala, E | 1 |
| Ahluwalia, M; Givertz, MM; Mehra, MR | 1 |
| Abnousi, F; Bhatt, DL; Deliargyris, EN; Desai, M; Ding, VY; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Sundaram, V; White, HD; Yang, L; Yong, CM | 1 |
| Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Vaduganathan, M; White, HD | 1 |
| Abdalla, FH; Adefegha, SA; Bertoncheli, CM; Casali, EA; Castilhos, LG; Doleski, PH; Leal, CAM; Leal, DBR; Moritz, CEJ; Pereira, RS; Rezer, JFP; Santos, KF; Santos, RCV; Silveira, KL; Stainki, DR | 1 |
| Bowman, S; Gass, J; Weeks, P | 1 |
| Bhatt, DL; Deliargyris, EN; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
| Chatterjee, S; Mushiyev, S; Nairooz, R; Pekler, G; Sardar, P; Visco, F | 1 |
| Cheng, D; Forman, MB; Gillespie, DG; Jackson, EK | 1 |
| Dobesh, PP; Oestreich, JH | 1 |
| Price, MJ | 1 |
| Bhatt, DL; Chew, DP; Dauerman, HL; Gibson, CM; Gruberg, L; Harrington, RA; Mahaffey, KW; Stone, GW; White, HD | 1 |
| Aoyama, H; Asano, M; Hirai, F; Irie, R; Kamiyama, Y; Kawashima, S; Kimura, K; Kono, Y; Nakatani, T; Ohtoshi, M; Ozawa, K; Shimahara, Y; Tobe, T; Uchida, K; Ukikusa, M; Yamato, T; Yasuda, K | 1 |
| Dvorák, V; Novotný, A | 1 |
2 review(s) available for adenosine monophosphate and Complication, Postoperative
| Article | Year |
|---|---|
Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials.
Topics: Adenosine Monophosphate; Female; Hemorrhage; Humans; Male; Models, Biological; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; PubMed; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thrombosis | 2014 |
Cangrelor: Pharmacology, Clinical Data, and Role in Percutaneous Coronary Intervention.
Topics: Adenosine Monophosphate; Coronary Artery Disease; Humans; Injections, Intravenous; Percutaneous Coronary Intervention; Postoperative Complications; Purinergic P2Y Receptor Antagonists | 2017 |
4 trial(s) available for adenosine monophosphate and Complication, Postoperative
| Article | Year |
|---|---|
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
Topics: Adenosine Monophosphate; Administration, Oral; Aged; Cause of Death; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Global Health; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Survival Rate; Ticlopidine; Time Factors | 2017 |
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).
Topics: Adenosine Monophosphate; Aged; Anticoagulants; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Treatment Outcome | 2017 |
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPIO
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States | 2018 |
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
Topics: Adenosine Monophosphate; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Survival Rate; Treatment Outcome | 2012 |
8 other study(ies) available for adenosine monophosphate and Complication, Postoperative
| Article | Year |
|---|---|
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia.
Topics: Adenosine Monophosphate; Anticoagulants; Cardiac Surgical Procedures; Female; Follow-Up Studies; Forecasting; Heparin; Humans; Middle Aged; Platelet Aggregation Inhibitors; Platelet Factor 4; Postoperative Complications; Thrombocytopenia | 2019 |
A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19.
Topics: Adenosine Monophosphate; Adult; Alanine; Algorithms; Antiviral Agents; Clinical Decision-Making; COVID-19; COVID-19 Testing; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prospective Studies; Quality Improvement; SARS-CoV-2; Severity of Illness Index; Treatment Outcome | 2020 |
Sepsis induced by cecal ligation and perforation (CLP) alters nucleotidase activities in platelets of rats.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Platelets; Cecum; Humans; Ligation; Male; Postoperative Complications; Rats; Rats, Wistar; Sepsis | 2017 |
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series.
Topics: Adenosine Monophosphate; Administration, Oral; Aged; Aged, 80 and over; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Care; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Stents; Treatment Outcome | 2019 |
A novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesions.
Topics: Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Administration, Intravaginal; Animals; Cyclic AMP; Mice, Inbred C57BL; Postoperative Complications; Time Factors; Tissue Adhesions | 2014 |
Cangrelor for treatment during percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Stents | 2014 |
The effects of heterologous liver cross-hemodialysis on adenylate energy charge of the remnant liver after major hepatic resection.
Topics: Adenosine Monophosphate; Animals; Hepatic Encephalopathy; Liver; Male; Mitochondria, Liver; Phosphorylation; Postoperative Complications; Rabbits; Renal Dialysis; Swine | 1982 |
[Influence of gynecologic surgery on the blood concentration of adenosine phosphate].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Female; Genital Diseases, Female; Humans; Hysterectomy; Postoperative Complications | 1976 |